418 related articles for article (PubMed ID: 15590984)
1. Effects of overexpression of CXCL10 (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation.
Nagpal ML; Chen Y; Lin T
J Endocrinol; 2004 Dec; 183(3):585-94. PubMed ID: 15590984
[TBL] [Abstract][Full Text] [Related]
2. The involvement of epoxygenase metabolites of arachidonic acid in cAMP-stimulated steroidogenesis and steroidogenic acute regulatory protein gene expression.
Wang X; Shen CL; Dyson MT; Yin X; Schiffer RB; Grammas P; Stocco DM
J Endocrinol; 2006 Sep; 190(3):871-8. PubMed ID: 17003287
[TBL] [Abstract][Full Text] [Related]
3. Low concentrations mono-butyl phthalate stimulates steroidogenesis by facilitating steroidogenic acute regulatory protein expression in mouse Leydig tumor cells (MLTC-1).
Wang Y; Song L; Hong X; Cui L; Zhang Z; Xiao H; Zhou J; Wang X
Chem Biol Interact; 2006 Dec; 164(1-2):15-24. PubMed ID: 16999944
[TBL] [Abstract][Full Text] [Related]
4. Functional assessment of the calcium messenger system in cultured mouse Leydig tumor cells: regulation of human chorionic gonadotropin-induced expression of the steroidogenic acute regulatory protein.
Manna PR; Pakarinen P; El-Hefnawy T; Huhtaniemi IT
Endocrinology; 1999 Apr; 140(4):1739-51. PubMed ID: 10098511
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
[TBL] [Abstract][Full Text] [Related]
7. Monobutyl phthalate inhibits steroidogenesis by downregulating steroidogenic acute regulatory protein expression in mouse Leydig tumor cells (MLTC-1).
Wang YB; Song L; Cui LB; Hong X; Zhang ZD; Wang XR
J Toxicol Environ Health A; 2007 Jun; 70(11):947-55. PubMed ID: 17479410
[TBL] [Abstract][Full Text] [Related]
8. Involvement of protein kinase C and cyclic adenosine 3',5'-monophosphate-dependent kinase in steroidogenic acute regulatory protein expression and steroid biosynthesis in Leydig cells.
Jo Y; King SR; Khan SA; Stocco DM
Biol Reprod; 2005 Aug; 73(2):244-55. PubMed ID: 15814901
[TBL] [Abstract][Full Text] [Related]
9. Blocking BRE expression in Leydig cells inhibits steroidogenesis by down-regulating 3beta-hydroxysteroid dehydrogenase.
Miao J; Chan KW; Chen GG; Chun SY; Xia NS; Chan JY; Panesar NS
J Endocrinol; 2005 Jun; 185(3):507-17. PubMed ID: 15930177
[TBL] [Abstract][Full Text] [Related]
10. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
[TBL] [Abstract][Full Text] [Related]
11. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.
Goldberg-Bittman L; Neumark E; Sagi-Assif O; Azenshtein E; Meshel T; Witz IP; Ben-Baruch A
Immunol Lett; 2004 Mar; 92(1-2):171-8. PubMed ID: 15081542
[TBL] [Abstract][Full Text] [Related]
12. Study on the mechanism of trichlorfon-induced inhibition of progesterone synthesis in mouse leydig tumor cells (MLTC-1).
Hong X; Qu J; Wang Y; Sun H; Song L; Wang S; Wang X
Toxicology; 2007 May; 234(1-2):51-8. PubMed ID: 17350742
[TBL] [Abstract][Full Text] [Related]
13. Cordyceps sinensis and its fractions stimulate MA-10 mouse Leydig tumor cell steroidogenesis.
Huang BM; Ju SY; Wu CS; Chuang WJ; Sheu CC; Leu SF
J Androl; 2001; 22(5):831-7. PubMed ID: 11545297
[TBL] [Abstract][Full Text] [Related]
14. Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke.
Wang X; Li X; Schmidt DB; Foley JJ; Barone FC; Ames RS; Sarau HM
Mol Pharmacol; 2000 Jun; 57(6):1190-8. PubMed ID: 10825390
[TBL] [Abstract][Full Text] [Related]
15. cAMP-independent signaling regulates steroidogenesis in mouse Leydig cells in the absence of StAR phosphorylation.
Manna PR; Chandrala SP; Jo Y; Stocco DM
J Mol Endocrinol; 2006 Aug; 37(1):81-95. PubMed ID: 16901926
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CXCL10 in human prostate LNCaP cells activates its receptor (CXCR3) expression and inhibits cell proliferation.
Nagpal ML; Davis J; Lin T
Biochim Biophys Acta; 2006 Sep; 1762(9):811-8. PubMed ID: 16934957
[TBL] [Abstract][Full Text] [Related]
17. Perfluorododecanoic acid-induced steroidogenic inhibition is associated with steroidogenic acute regulatory protein and reactive oxygen species in cAMP-stimulated Leydig cells.
Shi Z; Feng Y; Wang J; Zhang H; Ding L; Dai J
Toxicol Sci; 2010 Apr; 114(2):285-94. PubMed ID: 20100736
[TBL] [Abstract][Full Text] [Related]
18. Chrysin, a natural flavonoid enhances steroidogenesis and steroidogenic acute regulatory protein gene expression in mouse Leydig cells.
Jana K; Yin X; Schiffer RB; Chen JJ; Pandey AK; Stocco DM; Grammas P; Wang X
J Endocrinol; 2008 May; 197(2):315-23. PubMed ID: 18434361
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation.
Sirianni R; Chimento A; Malivindi R; Mazzitelli I; Andò S; Pezzi V
Cancer Res; 2007 Sep; 67(17):8368-77. PubMed ID: 17804753
[TBL] [Abstract][Full Text] [Related]
20. Chemokine production and chemokine receptor expression by human glioma cells: role of CXCL10 in tumour cell proliferation.
Maru SV; Holloway KA; Flynn G; Lancashire CL; Loughlin AJ; Male DK; Romero IA
J Neuroimmunol; 2008 Aug; 199(1-2):35-45. PubMed ID: 18538864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
